Company Profile LogoCheckpoint Therapeutics

Checkpoint Therapeutics is an immuno-oncology biopharmaceutical company specializing in cancer therapy development.

Edit IconSuggest an Edit
Health Care
Biotechnology
Pharmaceutical
Therapeutics
Oncology

    Unlock insights on Checkpoint Therapeutics and 2M+ companies now!

    About Checkpoint Therapeutics

    Checkpoint Therapeutics mainly engages in advancing the development of cancer immunotherapy and targeted oncology treatments. It is dedicated to developing and bringing cancer therapies to market faster and actively pursuing product purchases, in-licensing, and co-development opportunities that align with its areas of expertise. The company provides a streamlined approach that lowers risk and accelerates the development and commercialization of oncology drugs, ensuring more patients, payors, and

    Company Highlights
    Year Founded

    2014

    icon-altEmployees

    21

    Location (HQ)

    USA

    Since Last Funding

    1 year 3 months

    Monthly Website Visitors

    17.3K

    icon-altTotal Investment Amt

    $10M

    Last Funding Round

    Post Ipo Equity

    icon-altYoY Headcount Growth

    10.47%

    Key Metrics

    Senior Hires

    NameLinkedin ProfilePositionDate Joined
    John Doehttps://www.linkedin.com/in/johndoeCEOCEO
    Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
    John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
    Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
    Get API access to complete private company database with growth metrics from 15 sources

    Similar Companies

    Pharmaceutical

    Health Care

    Biotechnology

    Pharmaceuticals

    Therapeutics

    Pharmaceutical Manufacturing

    Oncology